Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide with or without increased NEAT in type 2 diabetes
NL-OMON39218Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Jan 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Percent change in HbA1c and Percent change in weight. Started Jan 2013; status: active, not recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON39218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39218.